The relationship between somatostatin, epidermal growth factor, and steroid hormone receptors in breast cancer

Cancer

Volumn 64, Issue 6, 1989, Pages 1254-1260

  Reubi, Jean‐Claude ^a   Torhorst, Joachim ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; RADIOISOTOPE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; STEROID RECEPTOR;

BREAST CANCER; CLINICAL ARTICLE; FEMALE; HISTOLOGY; HORMONAL THERAPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AUTORADIOGRAPHY; BREAST NEOPLASMS; FEMALE; HUMAN; IODINE RADIOISOTOPES; MIDDLE AGE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, CELL SURFACE; RECEPTORS, NEUROTRANSMITTER; RECEPTORS, SOMATOSTATIN; RECEPTORS, STEROID; SOMATOSTATIN;

EID: 0024439360     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19890915)64:6<1254::AID-CNCR2820640615>3.0.CO;2-D     Document Type: Article

References (38)

1. Somatostatin
2. Somatostatin mediation of adenohy‐pophysial secretion
3. Somatostatin in the central nervous system: Physiology and pathological modifications
4. Distribution of somatostatin receptors in the human brain: An autoradiographic study
5. Specific high affinity binding for somatostatin‐28 on pancreatic β‐cells: Differences with brain somatostatin receptors
6. High density of somatostatin receptors in pituitary tumors from acromegalic patients
7. Somatostatin receptors in human growth hormone and prolactin‐secreting pituitary adenomas
8. Specific somatostatin receptors on human pituitary adenoma cell membranes
9. Visualization of somatostatin receptors and correlation with immunoreactive GH and PRL in human pituitary adenomas: Evidence for different tumor subclasses
10. Hormone‐producing gastrointestinal tumor contain high density of somatostatin receptors
11. A somatostatin analogue inhibits chondrosarcoma and insulinoma tumor growth
12. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system
13. High incidence of somatostatin receptors in human meningiomas: Biochemical characterization
14. Somatostatin receptors in human endocrine tumors
15. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells
16. Epidermal‐growth‐factor receptors and oestrogen receptors in human breast cancer
17. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progesterone receptor levels
18. Epidermal growth factor receptors in human breast cancer
19. Expression of epidermal growth factor receptors (EGFR) on breast carcinomas in relation to growth fractions, estrogen receptor status and morphological criteria
20. Amplified and over expressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma
21. Epidermal growth factor receptors in primary human breast and bladder cancer: Relation to tumor differentiation, invasion and patient survival
22. Epidermal‐growth‐factor receptor status as predictor of early recurrence of and death from breast cancer
23. 1 rat pituitary cells
24. Localization of epidermal growth factor receptors in the human prostate by biochemical and immunocytochemical methods
25. 125I]epidermal growth factor binding and receptor distribution in psoriasis
26. Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation‐dependent relationship in glial tumors
27. EGF receptors in human breast cancer on viable and necrotic tumor cells
28. Phorbol ester and epidermal growth factor receptors in human breast cancer
29. Cytosol estrogen and progesterone receptor levels measured in normal and pathological tissue of endometrium, endocervical mucosa and cervical vaginal portion
30. Growth fractions and estrogen receptors in human breast cancers as determined in situ with monoclonal antibodies
31. Histological grading and prognosis in breast cancer
32. Correlative study on neuro‐endocrine differentiation and presence of somatostatin receptors in breast carcinomas
33. Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas
34. Long‐term treatment of acromegaly with the somatostatin analog SMS 201–995
35. New somatostatin molecule for management of endocrine tumors
36. Longterm treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases
37. Autocrine and paracrine regulation of human breast cancer
38. Peptide growth factors are multifunctional